Results
Aurobindo Pharma Q2 FY27 Revenue Hits ₹10,263 Crores
Aurobindo Pharma reported record Q2 FY27 revenue of ₹10,263 crores, up 24% YoY, with EBITDA of ₹2,156 crores and 21% margin.
Management provided FY27 guidance for double-digit revenue growth, EBITDA e
